India has been slow to take advantage of the emergency approval of Covaxin, which received authorisation along with Oxford AstraZeneca in January. Emergency regulatory approval was granted the Indian vaccine while the third phase of the trial was still underway, but now preliminary data has revealed that it is 81 % effective.
from Sputnik News - World News, Breaking News & Top Stories https://ift.tt/2NZPKLo
via IFTTT
No comments:
Post a Comment